The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Randomized, Placebo-Controlled, Double-Blind Trial To Evaluate the Efficacy of Mupirocin for Eradicating Carriage of Methicillin-Resistant Staphylococcus aureus
Open accessAbstract
Mupirocin has been widely used for the clearance of nasal methicillin-resistant Staphylococcus aureus (MRSA) carriage during outbreaks, but no placebo-controlled trial has evaluated its value for eradicating MRSA carriage at multiple body sites in settings where MRSA is not epidemic. In a 1,500-bed teaching hospital with endemic MRSA, 102 patients colonized with MRSA were randomized into a double-blind, placebo-controlled trial and treated with either mupirocin (group M) or placebo (group P) applied to the anterior nares for 5 days; both groups used chlorhexidine soap for body washing. Follow-up screening, susceptibility testing, and genotyping were performed to evaluate treatment success, mupirocin or chlorhexidine resistance, and exogenous recolonization. At baseline, MRSA carriage was 60% in the nares, 38% in the groin, and 62% in other sites (skin lesions, urine). The MRSA eradication rate (all body sites) was 25% in group M (12 of 48 patients), compared to 18% in group P (9 of 50 patients; relative risk [RR], 0.72; 95% confidence interval [CI 95 ], 0.33 to 1.55). At the end of follow-up, 44% of patients (19 of 43) were free of nasal MRSA in group M, compared to 23% (11 of 44) in group P (RR, 0.57; CI 95 , 0.31 to 1.04). Ten patients developed MRSA infections (three in group M and seven in group P). One mupirocin treatment failure was due to exogenous MRSA recolonization. No MRSA isolate showed chlorhexidine resistance or high-level mupirocin resistance; however, we observed an association ( P = 0.003) between low-level mupirocin resistance at study entry (prevalence, 23%) and subsequent treatment failure in both study arms. These results suggest that nasal mupirocin is only marginally effective in the eradication of multisite MRSA carriage in a setting where MRSA is endemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Kluytmans, J., van Belkum, A., & Verbrugh, H. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.505 · Cited by 2,595
Epidemiology of Nosocomial Infections Caused by Methicillin-Resistant Staphylococcus aureus
THOMPSON, R. L., CABEZUDO, I., & WENZEL, R. P. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-309 · Cited by 651
Ayliffe, P. G. A. J., Buckles, M. A., Casewell, M. W., Cookson, B. D., Cox, R. A., Duckworth, G. J., French, G. L., Griffiths-Jones, M. A., Heathcock, R., Humphreys, H., et al. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90293-6 · Cited by 370
Cited by
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Grundmann, H., Aires-de-Sousa, M., Boyce, J., & Tiemersma, E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68853-3 · Cited by 1,101
Targeted versus universal decolonization to prevent ICU infection
Huang, S. S., Septimus, E., Kleinman, K., Moody, J., Hickok, J., Avery, T. R., Lankiewicz, J., Gombosev, A., Terpstra, L., Hartford, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207290 · Cited by 795
Hospital Epidemiology and Infection Control in Acute-Care Settings
Sydnor, E. R. M., & Perl, T. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-10 · Cited by 652
“Various decolonization regimens have been tried in general medical patients, with mixed results (126, 278, 302).”
The preventable proportion of nosocomial infections: an overview of published reports
Harbarth, S., Sax, H., & Gastmeier, P. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00150-6 · Cited by 621
Self-citationGemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., & Warren, R. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl017 · Cited by 439
Triclosan and Antimicrobial Resistance in Bacteria: An Overview
Yazdankhah, S. P., Scheie, A. A., H⊘iby, E. A., Lunestad, B.-T., Heir, E., Fotland, T. Ø., Naterstad, K., & Kruse, H. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.83 · Cited by 362
Community-acquired methicillin-resistant Staphylococcus aureus
Elston, D. M. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.04.018 · Cited by 308
Francois, P., Pittet, D., Bento, M., Pepey, B., Vaudaux, P., Lew, D., & Schrenzel, J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.254-260.2003 · Cited by 294
Self-citationSimor, A. E., Phillips, E., McGeer, A., Konvalinka, A., Loeb, M., Devlin, H. R., & Kiss, A. (2007) · Clinical Infectious Diseases · doi:10.1086/510392 · Cited by 286
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers
van Rijen, M., Bonten, M., Wenzel, R., & Kluytmans, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006216.pub2 · Cited by 286
Prevention and management of sternal wound infections
Lazar, H. L., Salm, T. V., Engelman, R., Orgill, D., & Gordon, S. (2016) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.01.060 · Cited by 279
Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?
Horner, C., Mawer, D., & Wilcox, M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks284 · Cited by 278
Methicillin-resistant Staphylococcus aureus in Community-acquired Skin Infections
Moran, G. J., Amii, R. N., Abrahamian, F. M., & Talan, D. A. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1106.040641 · Cited by 278
Eradication of Methicillin‐Resistant Staphylococcus aureus Carriage: A Systematic Review
Ammerlaan, H. S. M., Kluytmans, J. A. J. W., Wertheim, H. F. L., Nouwen, J. L., & Bonten, M. J. M. (2009) · Clinical Infectious Diseases · doi:10.1086/597291 · Cited by 277
Acton, D. S., Tempelmans Plat-Sinnige, M. J., van Wamel, W., de Groot, N., & van Belkum, A. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0602-7 · Cited by 263
Metadata
- Authors
- Harbarth, S., Dharan, S., Liassine, N., Herrault, P., Auckenthaler, R., & Pittet, D.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1999-06
- Volume
- 43
- Issue
- 6
- Pages
- 1412-1416
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2135399995
- Cited by
- 286
- References
- 25
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.